News|Articles|June 19, 2024
Insights on Evolving Treatment Strategies for Multiple Myeloma
The panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
Advertisement
Episodes in this series
Advertisement
Related to this article
At the 2026 National Summit on Hematologic Cancers, Kate Kennedy, MSN, APRN, flagged decisions where guidelines give nurses and APPs little direction.
Kate Kennedy, MSN, APRN, explains how Vanderbilt-Ingram's award-winning APP clinic moved bispecific step-up dosing out of the hospital.
Daisy Molina, EdD, MSN, RNC-LRN, explains how nurses can include caregivers in breast cancer care while keeping the patient's voice central.
In a 117-patient cohort, 35% waited over 60 days for neoadjuvant chemotherapy, most often because of added workup, second opinions or comorbidities.
Interviews with 15 young women with breast cancer show fertility preservation decisions unfold under time pressure and carry into survivorship.
FDA grants accelerated approval to amivantamab and hyaluronidase-lpuj for recurrent or metastatic head and neck squamous cell carcinoma.
Lisa Carter-Bawa, PhD, MPH, APRN, explains how nurses can counter lung cancer fatalism by pairing honesty with hope and using teach-back.
A COA survey found inconsistent coverage and upfront costs top the barriers to cellular therapy in independent community oncology practices.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Care Coordination Faces Neoadjuvant Chemotherapy Delays in MIBC
2
Teaching Communication as a Clinical Skill for Breast Cancer Care
3
Outpatient Tarlatamab Feasible in Community Oncology, Real-World Data Show
4
Breast Cancer Diagnosis: How Nurses Can Support the Whole Family
5